| Original language | English |
|---|---|
| Pages (from-to) | 572-573 |
| Number of pages | 2 |
| Journal | Schizophrenia Research |
| Volume | 195 |
| DOIs | |
| State | Published - May 2018 |
| Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by grant 13T-003 from the Stanley Medical Research Institute (JKW and SRM, co-PIs), NIMH Grant R01 MH095878 (MFG, PI), and by a Department of Veterans Affairs Research Enhancement Program (MFG, PI). Theravalues Corporation (Tokyo, Japan) generously donated drug and matched placebo capsules. The funding agencies and Theravalues Corporation had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.
Funding
This work was supported by grant 13T-003 from the Stanley Medical Research Institute (JKW and SRM, co-PIs), NIMH Grant R01 MH095878 (MFG, PI), and by a Department of Veterans Affairs Research Enhancement Program (MFG, PI). Theravalues Corporation (Tokyo, Japan) generously donated drug and matched placebo capsules. The funding agencies and Theravalues Corporation had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.
| Funders | Funder number |
|---|---|
| Theravalues Corporation | |
| National Institute of Mental Health | R01MH095878 |
| U.S. Food and Drug Administration | |
| U.S. Department of Veterans Affairs | |
| Stanley Medical Research Institute |
Keywords
- BDNF
- Cognition
- Curcumin
- Schizophrenia
